NASDAQ Companies

CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company, focused on […]

After exceptional sales in the California regions, BranchOut expands into 7 more states Several additional regions now reviewing BranchOut Food’s […]

Conference Call Today at 10 a.m. ET PARSIPPANY, N.J., Feb. 26, 2024 (GLOBE NEWSWIRE) — Lincoln Educational Services Corporation (Nasdaq: LINC) […]

FLORHAM PARK, N.J., Feb. 26, 2024 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage […]

Data expected to be shared during March corporate update With SAD cohorts complete, MAD cohorts to begin dosing in March […]

MoonLake Immunotherapeutics Announces Positive Feedback from both FDA and EMA on Regulatory Path for the Phase 3 Program of the […]

BOCA RATON, Fla., Feb. 26, 2024 (GLOBE NEWSWIRE) — Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions […]

PRINCETON, N.J., Feb. 26, 2024 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery […]

•  Net product revenue of $42.1M in 4Q and $50.7M for the year •  New England Journal of Medicine publication of […]

GAITHERSBURG, Md., Feb. 26, 2024 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), […]